BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4920656)

  • 1. Tumor immunity produced by the intradermal inoculation of living tumor cells and living Mycobacterium bovis (strain BCG).
    Zbar B; Bernstein I; Tanaka T; Rapp HJ
    Science; 1970 Dec; 170(3963):1217-8. PubMed ID: 4920656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T; Tokunaga T; Murohashi T
    J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG.
    Wainberg MA; Deutsch V; Weiss DW
    Br J Cancer; 1976 Nov; 34(5):500-8. PubMed ID: 187207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.
    Zbar B; Tanaka T
    Science; 1971 Apr; 172(3980):271-3. PubMed ID: 4323415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract]   [Full Text] [Related]  

  • 6. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
    Kawahara M; Matsuo K; Honda M
    Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-GuĂ©rin strain of Mycobacterium bovis.
    Bartlett GL; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1972 Jan; 48(1):245-57. PubMed ID: 4568964
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential effects of two strains of BCG on transplantation immunity to SV40-induced tumors in hamsters.
    Fortner GW; Hanna MG; Coggin JH
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):62-7. PubMed ID: 4373753
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis.
    Yarkoni E; Rapp HJ
    Infect Immun; 1980 Jun; 28(3):887-92. PubMed ID: 6995326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE; Meyer TJ; Azuma I; Zbar B
    Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
    [No Abstract]   [Full Text] [Related]  

  • 12. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis.
    Zbar B; Bernstein ID; Bartlett GL; Hanna MG; Rapp HJ
    J Natl Cancer Inst; 1972 Jul; 49(1):119-30. PubMed ID: 4338767
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of tumor growth after intradermal injection of BCG extracts: a comparison of results in strain-2 guinea pigs from the National Institutes of Health and from the National Jewish Hospital and Research Center.
    Zbar B; Minden P; McClatchy JK; Rapp HJ
    J Natl Cancer Inst; 1976 Feb; 56(2):443-4. PubMed ID: 176390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between intradermal tumor suppression and tumor immunity.
    Bartlett GL; Kreider JW; Purnell DM
    J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of microscopic lymph nodes metastases after injection of living BCG adjacent to the primary tumor.
    Smith HG; Bast RC; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Dec; 55(6):1345-52. PubMed ID: 1107574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei.
    Yarkoni E; Rapp HJ
    Oncology; 1982; 39(5):314-8. PubMed ID: 7099513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experiments.
    Rella W; Chaput B
    Oncology; 1978; 35(3):136-42. PubMed ID: 209379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
    Boyle MD; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of tumor growth and induction of specific tumor immunity by intradermal inoculation of a mixture of living tumor cells and live Mycobacterium bovis in syngeneic mice.
    Tanaka T; Tokunaga T
    Gan; 1971 Oct; 62(5):433-4. PubMed ID: 4946562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.